FDA Targets Alzheimer's Products In Supplement Crackdown
The U.S. Food and Drug Administration said Monday that it sent warning and advisory letters to 17 companies selling products purporting to treat Alzheimer's disease and other illnesses without FDA approval....To view the full article, register now.
Already a subscriber? Click here to view full article